公司资料
Kronos Bio 股价、新闻与催化剂
- 股票代码:
- KRON
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for KRON.
公司概览
业务概览
Kronos Bio was an oncology company focused on epigenetic and transcriptional regulation in cancer before its restructuring and public-market decline. Its story centered on chromatin biology and targeted cancer therapy.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Kronos sat in oncology biotechnology.
商业模式特征
The business depended on clinical data, target validation, and the ability to convert epigenetic science into therapeutic value.
生物医药行业定位
Kronos belongs to the historical oncology-biotech set rather than the current live public-company universe.
未来催化剂
- Kronos is now mostly a legacy / closeout story, so the catalysts are transaction or asset-resolution updates rather than fresh pipeline milestones. The market no longer treats it like an active growth name.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。